官方服务：
资源简介：
SERS Data
应用场景：
创建时间：
2022-08-03
相关数据集
Table_9_Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection.docx
BackgroundLung cancer (LC) is a leading cause of cancer-deaths globally. Its lethality is due in large part to the paucity of accurate screening markers. Precision Medicine includes the use of omics t
NIAID Data Ecosystem30
LiBio: a study investigating liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer. LiBio
Background: The aim of this study was to investigate the clinical value of liquid biopsy as a primary source for variant analysis in lung cancer. In addition, we sought to characterize liquid biopsy v
NIAID Data Ecosystem20
Supplementary Table S2 from OvaPrint—A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer
Table S2: Tissue source for samples used in RRBS. Table summarizes the source of each tissue sample with totals annotated in the final row and final column.
NIAID Data Ecosystem10
Additional file 4: of Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
Details of all somatic mutations. Coding sequence mutations, amino acid changes, CADD score, ALT read counts and MAF for tumour, pre-surgery plasma, post-surgery plasma, and WBC are listed. (XLSX 42 k
NIAID Data Ecosystem20
